ClassID:

109954

C12N2710/20033 - CPC Classification

Classification description:

dsDNA viruses; Details; Papillomaviridae Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Recent Application in this class:
#1
20250092113
2025-03-20

Multimeric T-Cell Modulatory Polypeptides and Methods of Use Thereof

#2
20240368229
2024-11-07

Cell-Penetrating Peptides and Methods of Use Thereof

#3
20240216527
2024-07-04

VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS

#4
20230391830
2023-12-07

CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS

#5
20220389079
2022-12-08

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

#6
20220387619
2022-12-08

Virus-like particle conjugates for diagnosis and treatment of tumors

#7
20220251574
2022-08-11

CELL CAPABLE OF ACTIVATING IMMUNE SYSTEM, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID CELL

#8
20220088216
2022-03-24

Virus-like particle conjugates for diagnosis and treatment of tumors

#9
20210393797
2021-12-23

VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS

#10
20210206811
2021-07-08

Cell-penetrating peptides and methods of use thereof

#11
20200291072
2020-09-17

Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors

#12
20200188529
2020-06-18

Virus-like particle conjugates for diagnosis and treatment of tumors

#13
20190083647
2019-03-21

Virus-like particle conjugates for diagnosis and treatment of tumors

#14
20170281691
2017-10-05

Methods for constructing antibiotic resistance free vaccines

#15
20170028045
2017-02-02

Methods for constructing antibiotic resistance free vaccines

#16
20160250324
2016-09-01

Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses

#17
20160228568
2016-08-11

Virus-like particle conjugates for diagnosis and treatment of tumors

#18
20160030557
2016-02-04

Vaccines having an antigen and interleukin-23 as an adjuvant

#19
20150125480
2015-05-07

Methods for constructing antibiotic resistance free vaccines

#20
20130064849
2013-03-14

METHODS TO TREAT AND PREVENT CARDIOVASCULAR DISEASE USING HUMAN PAPILLOMAVIRUS VACCINES

#21
20060104991
2006-05-18

Methods for constructing antibiotic resistance free vaccines